These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37130749)

  • 1. Familial hypercholesterolaemia and emerging therapeutics.
    Farias FI; Kim SM; Shapiro MD
    Heart; 2023 Sep; 109(19):1486-1493. PubMed ID: 37130749
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of phenotypic familial hypercholesterolaemia and elevated lipoprotein(a) in patients with premature coronary artery disease: implications for developing cardiometabolic services.
    Wong RS; Lan NSR; Rankin JM; Bell DA; Dwivedi G
    Coron Artery Dis; 2022 Aug; 33(5):421-423. PubMed ID: 35044334
    [No Abstract]   [Full Text] [Related]  

  • 3. Manifestations of familial hypercholesterolaemia.
    Gillett MJ; Burnett JR
    Intern Med J; 2005 Jan; 35(1):63-4. PubMed ID: 15667473
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of familial hypercholesterolaemia: a major treatment gap in preventative cardiology.
    Bates TR; Burnett JR; van Bockxmeer FM; Hamilton S; Arnolda L; Watts GF
    Heart Lung Circ; 2008 Oct; 17(5):411-3. PubMed ID: 17683986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversies in familial hypercholesterolaemia: recommendations of the NICE Guideline Development Group for the identification and management of familial hypercholesterolaemia.
    Minhas R; Humphries SE; Qureshi N; Neil HA;
    Heart; 2009 Apr; 95(7):584-7; discussion 587-91. PubMed ID: 19168470
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnosis and treatment of familial hyperlipaemia episodes].
    Mantilla Morató T; Alonso R; Mata P
    Aten Primaria; 2004 Dec; 34(10):557-64. PubMed ID: 15607060
    [No Abstract]   [Full Text] [Related]  

  • 7. Familial hypercholesterolaemia in Australia: new insights and developments.
    Hamilton-Craig IR; Watts GF
    Med J Aust; 2013 Feb; 198(2):72-3. PubMed ID: 23373481
    [No Abstract]   [Full Text] [Related]  

  • 8. Understanding the efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia.
    Pirillo A; Catapano AL
    Eur J Prev Cardiol; 2022 May; 29(5):829-831. PubMed ID: 35148370
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment goals in familial hypercholesterolaemia-time to consider low-density lipoprotein-cholesterol burden.
    Langslet G; Holven KB; Bogsrud MP
    Eur J Prev Cardiol; 2022 Dec; 29(17):2278-2280. PubMed ID: 34935933
    [No Abstract]   [Full Text] [Related]  

  • 10. [Severe coronary artery disease in premenopausal woman with familial hypercholesterolaemia].
    Roszczyk N; Wierzbowska-Drabik K; Kręcki R; Kasprzak JD
    Kardiol Pol; 2013; 71(5):505-8. PubMed ID: 23788092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial hypercholesterolaemia.
    Nair DR; Sharifi M; Al-Rasadi K
    Curr Opin Cardiol; 2014 Jul; 29(4):381-8. PubMed ID: 24870549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial hypercholesterolaemia: clinical features and management.
    Pottle A
    Nurs Stand; 2005 Dec 14-2006 Jan 3; 20(14-16):55-65; quiz 66. PubMed ID: 16372559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial hypercholesterolaemia: underdiagnosed and undertreated.
    Rees A
    Eur Heart J; 2008 Nov; 29(21):2583-4. PubMed ID: 18840878
    [No Abstract]   [Full Text] [Related]  

  • 14. A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy).
    Descamps OS; Van Caenegem O; Hermans MP; Balligand JL; Beauloye C; Bondue A; Carlier S; Castermans E; Chenot F; Claeys M; De Block C; de Leener A; De Meester A; Demeure F; De Raedt H; Desmet W; Elegeert I; Guillaume M; Hoffer E; Kacenelenbogen R; Lancellotti P; Langlois M; Leone A; Mertens A; Paquot N; Vanakker O; Vanoverschelde JL; Verhaegen A; Vermeersch P; Wallemacq C; Rietzschel E;
    Atherosclerosis; 2018 Oct; 277():369-376. PubMed ID: 30270073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular senescence, telomeres, and cardiovascular risk in familial hypercholesterolaemia.
    Banach M; Penson PE
    Eur J Prev Cardiol; 2022 May; 29(5):718-720. PubMed ID: 33624078
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tuberous xanthomas as the first manifestation of homozygous familial hypercholesterolaemia].
    Hammami H; Benmously R; Marrak H; Debbiche A; Souissi A; Ayed MB; Fenniche S; Mokhtar I
    Ann Dermatol Venereol; 2008 Dec; 135(12):892-4. PubMed ID: 19084711
    [No Abstract]   [Full Text] [Related]  

  • 17. INTERIM guidelines for the diagnosis and management of familial hypercholesterolaemia.
    Sullivan DR; Hamilton-Craig I; van Bockxmeer F; Watts GF;
    Heart Lung Circ; 2012 Mar; 21(3):159-62. PubMed ID: 22364837
    [No Abstract]   [Full Text] [Related]  

  • 18. Familial Hypercholesterolemia and Lipoprotein(a): Unraveling the Knot That Binds Them.
    Toth PP
    J Am Coll Cardiol; 2020 Jun; 75(21):2694-2697. PubMed ID: 32466884
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection and care of familial hypercholesterolaemia in the community: is there a role for the pharmacist?
    Krass I; Walker AT; Watts GF
    Int J Clin Pharm; 2012 Aug; 34(4):501-5. PubMed ID: 22622591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary hyperlipidemia.
    Teramoto T; Sasaki J; Ueshima H; Egusa G; Kinoshita M; Shimamoto K; Daida H; Biro S; Hirobe K; Funahashi T; Yokote K; Yokode M;
    J Atheroscler Thromb; 2008 Apr; 15(2):49-51. PubMed ID: 18480589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.